1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

por Agostini, Maria L, Schnell, Gretja, di Iulio, Julia, Kohli, Anita, Shapiro, Adrienne E, Sarkis, Elias H, Inman, Dave, Peppercorn, Amanda, Skingsley, Andrew, Gaffney, Leah A, Aldinger, Melissa, Hebner, Christy M, Cathcart, Andrea L
Publicado 2022

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

por Keymeulen, Bart, van Maurik, André, Inman, Dave, Oliveira, João, McLaughlin, Rene, Gittelman, Rachel M., Roep, Bart O., Gillard, Pieter, Hilbrands, Robert, Gorus, Frans, Mathieu, Chantal, Van de Velde, Ursule, Wisniacki, Nicolas, Napolitano, Antonella
Publicado 2020

A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)

por Patel, Jatin, Bass, Damon, Beishuizen, Albertus, Bocca Ruiz, Xavier, Boughanmi, Hatem, Cahn, Anthony, Colombo, Hugo, Criner, Gerard J., Davy, Katherine, de-Miguel-Díez, Javier, Doreski, Pablo A., Fernandes, Sofia, François, Bruno, Gupta, Anubha, Hanrott, Kate, Hatlen, Timothy, Inman, Dave, Isaacs, John D., Jarvis, Emily, Kostina, Natalia, Kropotina, Tatiana, Lacherade, Jean-Claude, Lakshminarayanan, Divya, Martinez-Ayala, Pedro, McEvoy, Charlene, Meziani, Ferhat, Monchi, Mehran, Mukherjee, Sumanta, Muñoz-Bermúdez, Rosana, Neisen, Jessica, O'Shea, Ciara, Plantefeve, Gaëtan, Schifano, Lorrie, Schwab, Lee E., Shahid, Zainab, Shirano, Michinori, Smith, Julia E., Sprinz, Eduardo, Summers, Charlotte, Terzi, Nicolas, Tidswell, Mark A., Trefilova, Yuliya, Williamson, Russell, Wyncoll, Duncan, Layton, Mark
Publicado 2023